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This work  describes  the  antimicrobial,  antioxidant  and  anticholinesterase  activities  in vitro  of  organic
extracts  from  fourteen  seaweeds,  eleven  sponges,  two  ascidians,  one  bryozoan,  and  one sea anemone
species  collected  along  the  Brazilian  and  Spanish  coast,  as well  as  the isolation  of  the diterpene  (4R,  9S,
14S)-4-acetoxy-9,14-dihydroxydolast-1(15),7-diene  (1)  and halogenated  sesquiterpene  elatol  (2).
The most  promising  antimicrobial  results  for  cell  wall  bacteria  were  obtained  by  extracts  from  seaweeds
Laurencia  dendroidea  and  Sargassum  vulgare  var.  nanun  (MIC 250  g/ml),  and  by the bryozoan  Bugula  ner-
itina  (MIC  62.5  g/ml),  both  against  Staphylococcus  aureus.  As for antimollicutes,  extracts  from  seaweeds
showed  results  better  than  the  extracts  from  invertebrates.  Almost  all seaweeds  assayed  (92%)  exhib-
ited  some  antimicrobial  activity  against  mollicutes  strains  (Mycoplasma  hominis,  Mycoplasma  genitalium,
Mycoplasma  capricolum  and Mycoplasma  pneumoniae  strain  FH).  From  these  seaweeds,  A1 (Canistrocarpus
cervicornis),  A11  (Gracilaria  sp.)  and  A4  (Lobophora  variegata)  showed  the  best  results  for  M. pneumoniae
strain  FH  (MIC  250  g/ml).  Furthermore,  compounds  1  and  2  were  also assayed  against  mollicutes  strains
M. hominis,  M.  genitalium,  M. capricolum,  M. pneumoniae  strain  129  and  M. pneumoniae  strain  FH,  which
showed  MIC  > 100  g/ml.  Antioxidant  activities  of  extracts  from  these  marine  organisms  were  inactive,
except  for  E7  (from  sponge  Ircinia  sp.),  which  exhibited  moderated  antioxidant  activities  for two  methods
assayed  (IC50 83.0  ±  0.1 g/ml,  and  52.0  ± 0.8 mg AA/g, respectively).  Finally,  for the  anticholinesterase
activity,  all  the 29  samples  evaluated  (100%)  exhibited  some  level  of activity,  with  IC50 < 1000  g/ml.
From  these,  seaweeds  extracts  were  considered  more  promising  than  marine  invertebrate  extracts  [A10
(IC50 14.4  ± 0.1 g/ml),  A16 (IC50 16.4  ± 0.4  g/ml)  and  A8  (IC50 14.9  ±  0.5  g/ml)].  The  ﬁndings  of  this
work  are  useful  for further  research  aiming  at isolation  and  characterization  of  active  compounds.
ileira© 2015  Sociedade  Bras
ntroduction
Marine organisms produce substances with different well-
eﬁned ecological functions. Moreover, some of these molecules
lso exhibit pharmacological properties such as antiviral (Sagar
t al., 2010; Guimarães et al., 2013), antifungal (Wattanadilok et al.,
007), antibacterial (Mancini et al., 2007), antiprotozoal (Santos
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et al., 2010; Veiga-Santos et al., 2010; Santos et al., 2011), cytotoxic
(Moore and Scheuer, 1971; Friedman et al., 2008; Wang, 2008),
anticancer (Rinehart et al., 1981; Simmons et al., 2005), antioxidant
(Utkina et al., 2010), and others. Advances in marine pharmacology
are demonstrated by several new compounds in pre- or clinical
evaluation (Costa-Lotufo et al., 2009; Molinski et al., 2009; Gerwick
and Moore, 2012).Despite having more than 8500 km of coastline, Brazilian stud-
ies concerning marine natural products related to drugs discovery
are still very scarce and have been mainly conducted in the south-
east of the country. So far only a few classes of Brazilian marine
 Ltda. All rights reserved.
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Box 1: Marine seaweeds collected for biological assays.
Species Collection locala Collection date Voucher
Phylum Ochrophytab
Canistrocarpus
cervicornis
Paraíso Beach,
Cabo de Santo
Agostinho, PE
(8◦21′ S; 34◦57′ W)
August 2009 SP 401.485
Dictyota
mertensii
Itapuama Beach,
Cabo de Santo
Agostinho, PE
(8◦17′ S; 34◦57′ W)
August 2009 MOUFPE
000.001
Lobophora
variegata
Calhetas Beach,
Cabo de Santo
Agostinho, PE
(8◦20′ S; 34◦56′ W)
August 2009 MOUFPE
000.002
Sargassum
vulgare var.
nanun
Boa Viagem Beach,
Recife, PE (8◦7′ S;
34◦53′ W)
August 2009 SP 401.486
Sargassum
vulgare var.
vulgare
Paraíso Beach,
Cabo de Santo
Agostinho, PE
(8◦21′ S; 34◦57′ W)
August 2009 MOUFPE
000.003
Padina
gymnospora
Boa Viagem Beach,
Recife, PE (08◦7′ S;
34◦53′ W)
August 2009 SP 401.479
Phylum Rhodophytac
Digenia simplex Suape Beach, Cabo
de  Santo
Agostinho, PE
(8◦22′ S; 34◦56′ W)
August 2009 SP 401.477
Gracilaria sp. Boa Viagem Beach,
Recife, PE (8◦7′ S;
34◦53′ W)
August 2009 SP 401.484
Laurencia
dendroidea
Suape Beach, PE
(8◦22′ S; 34◦56′ W)
August 2009 SP 401.478
Laurencia
translucida
Itapuama Beach,
Cabo de Santo
Agostinho, PE
(8◦17′ S; 34◦57′ W)
August 2009 –
Hypnea
musciformis
Paraíso Beach,
Cabo de Santo
Agostinho, PE
(8◦21′ S; 34◦57′ W)
August 2009 SP 401.483
Palisada
perforata
Suape Beach, Cabo
de  Santo
Agostinho, PE
(8◦22′ S; 34◦56′ W)
August 2009 MOUFPE
000.004
Phylum Chlorophytad
Anadyomene
saldanhae
Arraial dA´juda
Beach, Porto
Seguro, BA
(16◦29′ S; 39◦04′ W)
September
2011
–
Chaetomorpha
antennina
Suape Beach, Cabo
de  Santo, gostinho
PE (8◦22′ S;
34◦56′ W)
August 2009 MOUFPE
000.005
a All seaweeds were collected in the intertidal zone.
b Ochrophyta = brown seaweeds.
c Rhodophyta = red seaweeds.É.M. Bianco et al. / Revista Brasileir
rganisms have been investigated for their chemical and pharma-
ological properties (Teixeira, 2010). Therefore it is believed that
he identiﬁcation of Brazilian organisms with signiﬁcant biotech-
ological potential is an important tool for the discovery of new
rugs.
Considering the great biodiversity of Brazilian marine species,
he use of appropriate methodologies which could rapidly screen
ifferent marine sources for bioactive compounds is of great inter-
st. In a previous study concerning bioprospecting of marine
atural products from Brazilian coast, we have shown that Brazilian
eaweeds, as well as sponges, ascidians, octocorals and bryozoans,
an offer a rich source for the chemical study of novel bioac-
ive secondary metabolites with potential medicinal properties,
pecially as antibacterial, antifungal, antiprotozoal and antiviral
Bianco et al., 2013a).
In order to compare and complement different species of marine
rganisms, ﬁve marine sponge species from the Spanish coast were
ollected at intertidal and sublittoral sites of the Galician littoral
NW Spain), and also were screened for their biological potential.
 large number of compounds with unusual chemical diversity
nd remarkable biological activity have been isolated from marine
ponges (Nakao and Fusetani, 2010), the discovery of nucleoside
erivatives from the Tectitethya crypta (former Cryptotethya crypta)
n the 1950s by Bergmann and Feeney (1950, 1951) being a success-
ul example. It has led to artiﬁcial derivatives ARA-C (cytarabine)
nd ARA-A (vidarabine), which are used as anticancer and antivi-
al drugs, respectively (Molinski et al., 2009; Gerwick and Moore,
012). Eribulin mesylate (anticancer) is another recent example of
n approved drug obtained as a derivative from the natural prod-
ct halichondrin B, isolated from the sponge Halichondria okadai
Huyck et al., 2011).
With regard to this work, and complementing our previous
creening (Bianco et al., 2013a), the biotechnological potential of
rganic extracts from Brazilian and Spanish marine biodiversity,
nd the two already known compounds (1 and 2) isolated from the
raziliam seaweeds Canistrocarpus cervicornis and Laurencia den-
roidea, respectively, which were still being investigated, but now
valuated for different properties, such as antimicrobial, including
ntimollicutes (mollicutes are wall-less bacteria), antioxidant and
nticholinesterase. Furthermore, this work also showed for the ﬁrst
ime a screening for antimollicutes agents from Brazilian marine
rganisms.
aterials and methods
eneral
All chemicals used were of analytical grade; 2,2-diphenyl-
-picrylhydrazyl (DPPH), acetylcholinesterase (AChE) type VI-S,
rom electric eel 349 U/mg solid, 411 U/mg protein, 5,50-
ithiobis[2-nitrobenzoic acid] (DTNB), acetylthiocholine iodide
AChI), tris[hydroxymethyl] aminomethane (Tris buffer), dimethyl-
ulfoxide (DMSO) and Tween 40 were supplied by Sigma; solvents
ere purchased from Merck (Germany), Sinth (Brazil) and Vetec
Brazil), and used without further puriﬁcation. Solid support for
hromatography column (CC): silica gel (SiO2) Vetec (70–230 mesh;
30–400 mesh); TLC (SiO2 GF254 – Merck); 1H NMR  (299.99 MHz)
nd 13C NMR  (70.0 MHz) spectra were recorded on a Varian
nity Plus 300 spectrometer using deuterated chloroform (CDCl3)
ambridge as solvent and TMS  as internal standard.ollection of marine organisms
Seaweeds specimens (Rhodophyta, Pheophyceae, and Chloro-
hyta) were collected in the midlittoral zone of the northeasternd Chlorophyta = green seaweeds.
Brazilian coast, in August 2009/September 2011 (Box 1). The
epiphytic organisms from the seaweeds were manually cleaned
immediately after collection, and then air-dried. Voucher speci-
mens were deposited at the herbarium of the Instituto de Botânica
de São Paulo (SP, Brazil) and at the Museu de Oceanograﬁa, Depar-
tamento de Oceanograﬁa, Universidade Federal de Pernambuco
(Recife, PE, Brazil); Sponges were collected in Rio de Janeiro and
Spanish coast by free and SCUBA diving, at a depth of 1–19 m, in
July/October 2006 (Table 1), and the samples were immediately
frozen and lyophilized. The identiﬁcation of sponge material was
made by sections and spicules analysis. Tunicates, anemone and
bryozoa were collected by free diving in Armac¸ ão de Itapocoroy
670 É.M. Bianco et al. / Revista Brasileira de Farmacognosia 25 (2015) 668–676
Table 1
Marine invertebrates collected for biological assays.
Species Collection local Depth Collection date Voucher
Phylum Porifera
Aplysina fulva Forno Beach, RJ, Arraial do Cabo, RJ (22◦45′ S, 42◦00′ W)  1–3 m July 2006 MNRJ 13554
Amphimedon viridis Bonﬁm’s Island, Angra dos Reis, RJ (23◦01′ S, 44◦19′ W) 1–3 m July 2006 MNRJ 14517
Desmapsamma anchorata Bonﬁm’s Island, Angra dos Reis, RJ (23◦01′ S, 44◦19′ W) 1–3 m July 2006 MNRJ 14520
Desmacidon fruticosum Punta Fornelos, Spain (43◦26′ N, 8◦18′ W)  5–19 m October 2010 MNRJ 14514
Dysidea cf. fragilis Baixo Pereiro, Galicia, Spain (43◦28′48 N, 8◦15′23 W)  5–19 m October 2006 MNRJ 14516
Haliclona oculata Punta Fornelos, Spain (43◦26′ N, 8◦18′ W)  5–19 m October 2006 MNRJ 14515
Ircinia  sp. Punta Fornelos, Spain (43◦26′ N, 8◦18′ W) 5–19 m October 2006 MNRJ 14519
Polymastia robusta Punta Fornelos, Spain (43◦26′ N, 8◦18′ W)  5–19 m October 2006 MNRJ 14533
Tethya  maza Tarituba Beach, Paraty, RJ (23◦02′ S, 44◦35′ W) 1 m April 2004 MNRJ 14549
Petromica citrina Archipelago of Cagarras, Rio de Janeiro, RJ (23◦01′ S, 43◦11 W)  10 m August 2008 MNRJ 14539
Hymeniacidon heliophila Itaipu Beach, Niterói, RJ (22◦58′ S, 43◦03′ W)  1 m July 2006 MNRJ 14528
Phylum Urochordata
Didembun perlucidum Armac¸ão de Itapocoroy Bay, Penha, SC (26◦46′ S, 48◦36′ W) 2–3 m July 2014 –
Polyclinum sp. Armac¸ ão de Itapocoroy Bay, Penha, SC (26◦46′ S, 48◦36′ W)  2–3 m July 2014 –
Phylum Bryozoa
Bugula neritina Armac¸ ão do Itapocoroy Bay, Penha, SC (26◦46′ S, 48◦36′ W)  2–3 m July 2014 –
46′ S, 
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Bunodosoma caissarum Armac¸ ão de Itapocoroy Bay, Penha, SC (26◦
ay, Penha, SC, at a depth of 1–3 m,  in July 2014, and the
aterial identiﬁcation was made by Departamento de
ceanograﬁa at Universidade do Vale do Itajaí (Table 1).
reparation of the extracts
Air-dried seaweeds (100 g per species) were extracted at room
emperature by static maceration with different organic solvents;
xtracts A1, A3, A4, A5, A6, A7, A8, A9, A10, A11, A13, A15, A16 and
17 were obtained using a mixture of dichloromethane/methanol
2:1); extracts DE and HE were acquired using dichloromethane and
-hexane, respectively. The process was repeated ﬁve times during
5 days, using 50 ml  of solvent per extraction. All 16 crude sea-
eed extracts obtained were evaporated under reduced pressure
<50 ◦C).
The freeze-dried sponges material (100 g), from eleven spec-
mens, were extracted three times with acetone at room
emperature, and extracts acquired (E1, E2, E3, E4, E5, E6, E7, E8, E9,
10 and E11) were concentrated under reduced pressure (<50 ◦C).
Fresh frozen samples of two ascidians (100 g), one bryozoan
100 g) and one sea anemone (50 g) were extracted three times
ith methanol at room temperature and crude extracts (AS1, AS2,
1 and AN1, respectively) were evaporated to dryness under low
emperatures (<50 ◦C) on a rotary evaporator.
All extracts were submitted to biological screening assays.
ompounds isolation
Compounds 1 and 2 were previously isolated from C. cervicornis
nd L. dendroidea,  respectively (Born et al., 2012). NMR spectro-
copic data (1H and 13C), and comparison with data from literature
onﬁrmed their identity (Garcia et al., 2009; Lhullier et al., 2009).
(4R, 9S, 14S)-4˛-Acetoxy-9ˇ,14˛-dihydroxydolast-1(15),7-diene
1): yellowish gum (130 mg). 1H NMR  (CDCl3): ı 2.71 (ddd, 1H,
 = 13.8, 13.8 and 5.4, H-2), ı 2.20 − 2.00 (m,  1H, J = 13.8, H-2),
 1.90 − 1.81 (m, 1H, H-3), ı 2.05 − 1.97 (m,  1H,H-3), ı 4.85
t, 1H, J = 3.0, H-4), ı 3.07 (dd,  1H, J = 15.0 and 4.8, H-6), ı 1.57
dd, 1H, J = 15.0 and 9.6, H-6), ı 5.54 (dd, 1H, J = 9.6 and 4.8, H-
), ı 1.50 − 1.47 (m, 1H, H-10), ı 1.77 − 1.70 (m,  1H, H-10), ı
.60 − 1.53 (m,  1H, H-11), ı 1.80 − 1.78 (m,  1H, H-11), ı 1.82 (d,
H, J = 14.4, H-13), ı 1.93 (d, 1H, J = 14.4, H-13), ı 4.82 (s, 1H, H-
5a), ı 4.93 (s, 1H, H-15b), ı 0.89 (s, 3H, H-16), ı 1.95 (qq,  1H, J = 6.9
nd 6.6, H-17), ı 1.03 (d, 3H, J = 6.6, H-18), ı 0.83 (d, 3H, J = 6.9,48◦36′ W)  1 m July 2014 –
H-19), ı 1.24 s, (3H, H-20), ı 2.16 (s, 3H, C(4) COOCH3), ı 3.75 (br
s, 1H, C(9) OH). 13C NMR  (CDCl3): ı 151.0 (C-1), ı 26.5 (C-2), ı 28.0
(C-3), ı 81.72 (C-4), ı 42.4 (C-5), ı 30.16 (C-6), ı 117.7 (C-7), ı 157.1
(C-8), ı 86.2 (C-9), ı 28.0 (C-10), ı 41.2 (C-11), ı 45.0 (C-12), ı 43.0
(C-13), ı 79.4 (C-14), ı 109.6 (C-15), ı 19.7 (C-16), ı 34.5 (C-17), ı
17.1 (C-18), ı 18.9 (C-19), ı 24.1 (C-20), ı 169.3 (C(4) COOCH3), ı
21.2 (C(4) COOCH3).
Elatol (2): colorless oil (19 mg). (CDCl3): ı 2.08 (br s, 1H, H-1),
ı 1.85 (m,  1H, H-4), ı 1.98 (d, 1H, J = 3.0, H-4), ı 1.63 (m,  1H, H-
5), ı 1.81 (m, 1H, H-5), ı 2.50 (dd, 1H, J = 3.0, 14.7, H-8), ı 2.36
(dm, 1H, 15.0, H-8), ı 4.15 (dd, 1H, J = 3.0, 6.6, H-9), ı 4.61 (d, 1H,
J = 2.7, H-10), ı 1.07 (s, 3H, H-12), ı 1.08 (s, 3H, H-13), ı 4.80 (br s,
1H, H-14a), ı 5.13 (br s, 1H, H-14b), ı 1.71 (br s, 3H, H-15). 13C NMR
(CDCl3): ı 38.6 (C-1), ı 128.0 (C-2), ı 124.1 (C-3), ı 29.3 (C-4), ı 25.6
(C-5), ı 49.1 (C-6), ı 140.7 (C-7), ı 38.0 (C-8), ı 72.1 (C-9), ı 70.8
(C-10), ı 43.1 (C-11), ı 20.7 (C-12), ı 24.2 (C-13), ı 115.8 (C-14), ı
19.4 (C-15).
Evaluation of antibacterial activity
The samples were evaluated against a different panel of
bacteria strains: one gram positive strain [Staphylococcus aureus
(ATCC25923)], two  gram negative [Pseudomonas aeruginosa
(ATCC27853), and Escherichia coli (ATCC25922)], and ﬁve mol-
licutes strains [Mycoplasma hominis (ATCC23114), Mycoplasma
genitalium (ATCC33530), Mycoplasma capricolum (ATCC27343),
Mycoplasma pneumoniae strain FH ATCC15531), and M. pneumo-
niae strain 129 (ATCC29342)]. For the growth of cell wall bacterial
strains, Müller–Hinton broth was used for S. aureus,  E. coli and P.
aeruginosa; SP4 (glucose) broth was used for M.  pneumoniae strain
FH, M.  pneumoniae strain 129, M. capricolum and M.  genitalium;  MLA
(arginine) broth was for M. hominis.
The microdilution broth assays were performed in sterile 96-
well microplates, as recommended by the Clinical and Laboratory
Standards Institute (CLSI, 2012) for cell wall bacteria and by Bébéar
and Robertson (1996) for mollicutes.
Antibacterial activities of the marine extracts were evaluated
by determination of the minimum inhibitory concentration (MIC),
which was deﬁned as the lowest concentration of the extract able
to inhibit bacterial growth. As a criterion to express the results, it
was established that extracts with MIC  lower than 10 g/ml were
considered to have an excellent antibacterial activity; extracts with
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IC  values between 10 and 100 g/ml were considered to have a
ood activity; extracts with MIC  values between 100 and 500 g/ml
ere considered to have moderate activity; extracts with MIC  val-
es between 500 and 1000 g/ml were considered to have low
ctivity, and extracts with MIC  above 1000 g/ml were considered
nactive. For pure compounds, only active samples with MIC  lower
han 100 g/ml (Machado et al., 2005) were considered.
Extracts were transferred to each microplate well with the
ppropriate culture medium, in order to obtain a twofold serial
ilution of the original extract in a 10% H2O/DMSO solution, obtain-
ng sample concentrations ranging between 1000 and 7.8 g/ml.
he inoculum containing 104–105 microorganisms per ml  was then
dded to each well. A number of wells were reserved in each plate
o test for sterility control (no inoculum added), positive controls
gentamycin, levoﬂoxacin and clarithromycin – depending on the
acterium under test), inoculum viability (no extract added), and
he DMSO inhibitory effect. The microplates were incubated at
7 ± 1 ◦C for 24 or 48 h (depending on the bacterium).
For mollicutes bacteria, the growth as well as MIC was  detected
y visual inspection of the medium color change, since acidiﬁcation
f the medium by glucose metabolizing species change the color
rom red to yellow, and alkalinization of the medium by arginine
etabolizing species change the color from orange to red, as indi-
ated by the phenol red dye present in the culture media (Benfatti
t al., 2010). For cell wall bacteria, MIC  was evaluated by a methano-
ic solution of triphenyl tetrazolium chloride (5 mg/ml) added into
ach well, where the presence of a reddish bacterial “dot” observed
t the bottom of each well indicated bacterial growth (Freires et al.,
010).
ntioxidant assay
etermination of DPPH free radical scavenging activity
The DPPH free radical scavenging activity was  determined using
he method as described by Blois (1958) with some modiﬁcation
Cavin et al., 1998; Braca et al., 2001). To 5 ml  of a methanol solution
f 1,1-diphenyl-2-picrylhydrazyl (DPPH) 0.002% in methanol, 50 l
f extract solutions (1000–62.5 g/ml) was added and the mixtures
ere incubated at room temperature for 30 min. The absorbance
as measured at 517 nm against a corresponding blank. Inhibition
ercentage of free radical DPPH (I%) was calculated in the follow-
ng way: I (%) = (Ablank − Asample/Ablank) × 100, where Ablank is the
bsorbance of the control reaction (a reaction with all the reagents
xcept the test extract), and Asample is the absorbance of the test
xtract. Tests were carried out in triplicate and the extract concen-
ration providing 50% inhibition (IC50) was obtained by plotting
xtract solution concentration versus inhibition percentage.
etermination of iron reducing power
The assay for the analysis of antioxidant activity by determina-
ion of the reduction potential was based on the method of Price
nd Butler, proposed by Waterman and Mole (1994), with adap-
ations. To the 100 l of the test solutions (extracts, diluted in
ethanol at a concentration of 1000 g/ml) was added 8.5 ml  of
eionized water. Then, 1 ml  of a 0.1 M FeCl3 solution was  added
nd after 3 min, 1 ml  of a potassium ferricyanide 0.08 M solution
as mixed. After 15 min, the absorbance of samples was  measured
n a spectrophotometer at 720 nm.  A blank solution was prepared
ccording to the above procedure, without adding the sample. A
tandard curve was performed using ascorbic acid solutions in con-
entrations ranging from 100 to 1000 g/ml (y = 0.0019x + 0.0698
R2 = 0.9967). The reduction potential was expressed in milligram
mg) of ascorbic acid (AA) equivalents per gram (g) of dried extract
mg  AA/g). Analysis was  performed in triplicate.armacognosia 25 (2015) 668–676 671
Determination of total phenolic content
Total phenolic content of the extracts was  determined with the
Folin–Ciocalteu’s reagent (FCR) according to Slinkard and Singleton
(1977) method. Each sample (0.5 ml,  1000 g/ml) was mixed with
2.5 ml  FCR (diluted 1:10, v/v) followed by 2 ml  of Na2CO3 (7.5%,
v/v) solution. The absorbance was  then measured at 765 nm after
incubation at 30 ◦C for 90 min. Results were expressed as milligram
(mg) gallic acid (GA) equivalents per gram (g) of dried extract (mg
GA/g). Analyses were performed in triplicate.
Acetylcholinesterase enzyme inhibitory assay
The Ellman method (Ellman et al., 1961) was  employed for the
quantiﬁcation of acetylcholinesterase activity, and the procedures,
with some modiﬁcations, are detailed in many recent publications
(Ingkaninan et al., 2003; Mata et al., 2007), as brieﬂy explained
below.
A buffer solution [330 l of 50 mM Tris–HCl buffer (pH 8)], plus
an extract solution [100 l (from 1000 to 7.81 g/ml in methanol)]
and 30 l of AChE solution containing 0.28 U/ml (50 mM Tris–HCl,
0.1% BSA) were incubated for 15 min. Subsequently, 75 l of a solu-
tion of AChI (0.023 mg/ml  in water) and 475 l of DTNB (3 mM in
Tris–HCl) were added and the ﬁnal mixture incubated for another
30 min  at room temperature. Absorbance of the mixture was mea-
sured at 405 nm.  A control mixture was prepared, using 100 l
of a solution similar to the sample mixture but with methanol
instead of sample. Inhibition (%) was  calculated as follows: I
(%) = 100 − (Asample/Acontrol) × 100; where Asample is the absorbance
of the sample containing the reactant and Acontrol the absorbance
of the reaction control. Tests were carried out in triplicate. Extract
concentration providing 50% inhibition (IC50) was  obtained from
the non-linear regression graph of the percentage inhibition against
extract concentration. The inhibitory concentration of 50% of AChE
(IC50) value was calculated from at least four different concen-
trations of the sample using the Origin 20 statistical package.
Galanthamine hydrobromide served as the positive control.
Results and discussion
This work describes the antimicrobial (including antimolli-
cutes), antioxidant, and anticholinesterase activities in vitro of
organic extracts from fourteen seaweed species [six Rhodophyta
(43%), six Ochrophyta (43%), and two Chlorophyta (14%)], and 15
marine invertebrate species (eleven sponges, two ascidians, one
bryozoan, and one sea anemone) collected along the Brazilian
coast (Box 1 and Table 1), as well as the antimollicutes activity of
the diterpene (4R, 9S, 14S)-4-acetoxy-9,14-dihydroxydolast-
1(15),7-diene (1) and the halogenated sesquiterpene elatol (2),
isolated from the seaweeds C. cervicornis and L. dendroidea,  respec-
tively. The chemical structures of compounds 1 and 2 have been
characterized by NMR  spectroscopic data (1H and 13C), and by com-
parison with literature data, which showed identical spectroscopy
data to that previously reported (Garcia et al., 2009; Lhullier et al.,
2009).A range of di- and tricyclic diterpenes has been isolated from
the brown seaweed C. cervicornis (= Dictyota cervicornis) (Vallim
et al., 2005). Similarly, many halogenated sesquiterpenes have been
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Table 2
Antibacterial screening of marine seaweeds and invertebrate extracts.
Species Extracts Bacterial strains
S. aureus (g/ml) E. coli (g/ml) P. aeruginosa (g/ml)
Seaweeds
Anadyomene saldanhae A17 – – –
Canistrocarpus cervicornis A1 500 – –
Chaetomorpha antennina A13 500 – –
Dictyota mertensii A15 500 – –
Digenia simplex A9 – – –
Gracilaria sp. A11 500 1000 –
Hypnea musciformis A10 1000 – –
Laurencia dendroidea A7 250 – –
Laurencia translucida A16 – – –
Lobophora variegata A4 500 – –
Padina gymnospora A3 1000 – –
Palisada perforata A8 – – –
Sagassum vulgare var. nanun A5 250 – –
Sargassum vulgare var. vulgare A6 1000 – –
Sponges
Amphimedon viridis E2 – – –
Aplysina fulva E1 – – –
Desmacidon fruticosum E4 1000
Desmapsamma anchorata E3 – – –
Dysidea cf. fragilis E5 1000
Haliclona oculata E6 – – –
Hymeniacidon heliophila E11 – – –
Ircinia sp. E7 – – –
Petromica citrina E9 – – –
Polymastia robusta E8 – – –
Tethya maza E10 – – –
Tunicates
Didembun perlucidum AS1 1000 – –
Polyclinum sp. AS2 – – –
Bryozoa
Bugula neritina B1 62.5 – –
Sea  anemone
Bunodosoma caissarum AN1 1000 – –
Gentamycin 2.5
D 1000
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5ata are presented as MIC  (g/ml); positive control = gentamycin; (–), no activity (>
solated from the red seaweed L. dendroidea (= Laurencia obtusa)
Machado et al., 2014).
ntibacterial assays
Extracts from seaweeds and marine invertebrates were tested
gainst the cell wall bacterial strains, as S. aureus (ATCC25923),
. aeruginosa (ATCC27853) and E. coli (ATCC 25922), and against
acteria with absence of a cell wall, as M.  hominis (ATCC23114),
.  genitalium (ATCC33530), M.  capricolum (ATCC27343), M.  pneu-
oniae strain FH (ATCC15531), and M.  pneumoniae strain 129
ATCC29342).
As a criterion to express the results, extracts with MIC  lower
han 1000 g/ml were considered active. However, for pure com-
ounds, only active samples with MIC  lower than 100 g/ml were
onsidered.
Fourteen species of seaweeds were assayed. 10 out of 14
pecies (71%) showed some activity against S. aureus and E. coli
A1 (C. cervicornis), A3 (Padina gymnospora), A4 (L. variegata),
5 (S. vulgare var. nanun), A6 (S. vulgare var. vulgare), A7
L. dendroidea), A10 (Hypnea musciformis), A11 (Gracilaria sp.),
13 (Chaetomorpha antennina),  and A15 (Dictyota mertensii)]. Of
hese, the most promising results (for bacteria with cell walls)
ere found for A5 and A7, which exhibited moderated activ-
ties (MIC 250 g/ml), while others showed low activity (MIC
00–1000 g/ml) (Table 2). g/ml).
Concerning antibacterial activity (bacteria with cell walls) from
invertebrates, the extract B1 (from bryozoan B. neritina) showed
the best results, particularly against S. aureus (MIC 62.5 g/ml)
(Table 2). Against mollicutes, the best results were observed for
the sponge Dysidea cf. fragilis (E5) that inhibited the growth of M.
genitalium (MIC 250 g/ml), M. capricolum (MIC 500 g/ml), and M.
pneumoniae strain FH (MIC 250 g/ml).
Regarding antimollicutes activity, extracts from seaweeds were
also better than extracts from invertebrates. Almost all seaweeds
assayed (92%) exhibited some antimicrobial activity against mol-
licutes strains (M.  hominis, M. genitalium,  M. capricolum and M.
pneumoniae strain FH). From these, A1 (C. cervicornis), A4 (L. var-
iegata)  and A11 (Gracilaria sp.) showed the best results for M.
pneumoniae strain FH (MIC 250 g/ml) (Table 3). Additionally,
compounds 1 and 2 were isolated from the brown seaweed C.
cervicornis and the red seaweed L. dendroidea, respectively. How-
ever, considering the criteria established to express the results
(MIC > 100 g/ml), compounds 1 and 2 were not active against M.
hominis, M. genitalium,  M. capricolum,  M.  pneumoniae strain 129,
and M.  pneumoniae strain FH (Table 4).
All the same, a range of activities has been described
for compounds 1 and 2. In a previous study we reported
the isolation and antifoulant properties of compound 1 and
different other diterpenes, as (4R,7R,14S)-4,7-diacetoxy-14-
hydroxydolast-1(15),8-diene, and isolinearol from C. cervicor-
nis. These compounds inhibited the establishment of the
mussel Perna perna (Bianco et al., 2009). In addition, we also
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Table  3
Antimollicutes (bacteria with absence of a cell wall) screening from marine seaweeds and invertebrate extracts.
Species Extracts Bacterial strains
M.  hominis (g/ml) M. genitalium (g/ml) M.  capricolum (g/ml) M.  pneumoniae strain FH (g/ml)
Seaweeds
Anadyomene saldanhae A17 – 1000 1000 1000
Canistrocarpus cervicornis A1 – 1000 1000 250
Chaetomorpha antennina A13 – 1000 1000 500
Dictyota mertensii A15 1000 1000 500 1000
Digenia  simplex A9 – – – –
Gracilaria sp. A11 – 500 500 250
Hypnea  musciformis A10 – 500 500 500
Laurencia dendroidea A7 – 1000 1000 –
Laurencia translucida A16 – 500 500 1000
Lobophora variegata A4 1000 500 500 250
Padina  gymnospora A3 – 1000 1000 500
Palisada perforata A8 – 1000 1000 1000
Sagassum vulgare var. nanun A5 – 1000 – 500
Sargassum vulgare var. vulgare A6 – 1000 – 500
Sponges
Amphimedon viridis E2 – 1000 – 1000
Aplysina fulva E1 – – – 1000
Desmacidon fruticosum E4 – 1000 – –
Desmapsamma anchorata E3 – 1000 1000 1000
Dysidea cf.  fragilis E5 1000 250 500 250
Haliclona oculata E6 – – – –
Hymeniacidon heliophila E11 – – – –
Ircinia  sp. E7 – – – –
Petromica citrina E9 – – – –
Polymastia robusta E8 – – – –
Tethya  maza E10 NT NT NT NT
Tunicates
Didembun perlucidum AS1 – 1000 – 1000
Polyclinum sp. AS2 – – – –
Bryozoa
Bugula  neritina B1 – – – 1000
Sea  anemone
5 
D >1000
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dBunodosoma caissarum AN1 – – 
Levoﬂoxacin 2.5 0.1
ata are presented as MIC  (g/ml); positive control = levoﬂoxacin; (–), no activity (
howed that a similar diterpene (4R,7R,14S)-4,7-diacetoxy-
4-hydroxydolast-1(15),8-diene, the major compound from C.
ervicornis, signiﬁcantly inhibited feeding by the sea urchin Lytech-
nus variegatus (Bianco et al., 2010). Similarly, the same compound
 was assayed as antiprotozoal and exhibited IC50 2.2 M,  12 M
nd 4.0 M for the promastigote, axenic amastigote and intracel-
ular amastigote forms of Leishmania amazonensis, respectively. In
his work the SI was 93 times less toxic to macrophages than to
he protozoan, and a progressive loss of mitochondrial membrane
otential and cell death in L. amazonensis, induced for this com-
ound, was demonstrated too (Santos et al., 2011). In a previous
tudy we showed that the anticoagulant and antiplatelet activi-
ies of compound 1 (Moura et al., 2011), as well as the inhibition
f mammal  Na+K+-ATPase properties of (4R, 9S, 14S)-4-acetoxy-
,14-dihydroxydolast-1(15),7-diene, isolated from C. cervicornis
Garcia et al., 2009).
able 4
ntimollicutes (bacteria with absence of a cell wall) screening from extracts and pure com
Extracts/compounds
M.  hominis (g/ml) M. genitalium (g/ml) M. capricolum (
DE 500 500 500 
1  >100 >100 >100 
HE  500 500 500 
2  >100 >100 >100 
Clarithromycin 0.125 0.25 0.5 
ata are presented as MIC (g/ml); positive control = clarithromycin; DE = dichloromet
endroidea;  1 = (4R, 9S, 14S)-4-acetoxy-9,14-dihydroxydolast-1(15),7-diene; 2 = elato– –
0.15 0.15
 g/ml); NT, not tested.
In a different work it was demonstrated that compound 2 also
exhibited antileishmanial and anti-trypanosomal activities (Santos
et al., 2010; Veiga-Santos et al., 2010), as well as acaricidal (Born
et al., 2012), and larvicidal activities (Bianco et al., 2013b).
The results here complement a previous study performed by
Bianco et al. (2013a), which showed the antimicrobial proper-
ties of Brazilians marine seaweeds [Osmundaria obtusiloba] and
invertebrates [Dragmaxia anomala, Dragmacidon reticulatum, Hal-
iclona (Halichoclona) sp., Leptogorgia punicea, Petromica citrina,
Trachycladus sp.]. However, for the ﬁrst time antimollicutes activi-
ties of marine seaweeds/invertebrates extracts were demonstrated.Antioxidant assays
One of the aims of this study was also to investigate the antiox-
idant activities of extracts by two  different methods, as free radical
pounds obtained from marine seaweeds.
Bacterial strains
g/ml) M. pneumoniae strain 129 (g/ml) M. pneumoniae strain FH (g/ml)
125 100
>100 >100
31.25 100
>100 >100
2 1
hane extract from seaweed C. cervicornis; HE = n-hexane extract from seaweed L.
l.
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Table 5
Phenolic content and antioxidant screening (by DPPH and iron-reducing methods) from marine seaweeds and invertebrate extracts.
Species Extracts Phenols content (mg  GA/g)a Reducing potential (mg  AA/g)b DPPH IC50 (g/ml)
Seaweeds
Anadyomene saldanhae A17 15.6 ± 0.6 10.6 ± 0.9 >1000
Canistrocarpus cervicornis A1 18.6 ± 0.9 28.0 ± 0.9 >1000
Chaetomorpha antennina A13 16.0 ± 0.9 1.8 ± 0.8 >1000
Dictyota mertensii A15 22.4 ± 0.8 71.3 ± 0.8 >1000
Digenia simplex A9 13.6 ± 0.6 70.6 ± 0.9 >1000
Gracilaria sp. A11 21.0 ± 0.8 1.3 ± 0.3 >1000
Hypnea musciformis A10 15.1 ± 0.4 – >1000
Laurencia dendroidea A7 14.6 ± 0.9 29.7 ± 0.3 >1000
Laurencia translucida A16 20.4 ± 0.2 25.9 ± 1.0 >1000
Lobophora variegata A4 14.5 ± 0.5 115.2 ± 0.6 >1000
Padina gymnospora A3 15.1 ± 0.4 – >1000
Palisada perforata A8 11.8 ± 0.5 – >1000
Sagassum vulgare var. nanun A5 24.1 ± 0.7 46.6 ± 0.8 >1000
Sargassum vulgare var. vulgare A6 24.9 ± 0.9 51.6 ± 0.8 >1000
Sponges
Amphimedon viridis E2 17.1 ± 0.1 – >1000
Aplysina fulva E1 12.2 ± 0.1 – >1000
Desmacidon fruticosum E4 21.2 ± 0.1 – >1000
Desmapsamma anchorata E3 24.3 ± 0.5 9.0 ± 0.9 >1000
Dysidea cf. fragilis E5 25.6 ± 1.0 – >1000
Haliclona oculata E6 17.6 ± 0.3 – >1000
Hymeniacidon heliophila E11 16.0 ± 0.4 – >1000
Ircinia sp. E7 61.9 ± 0.3 52.0 ± 0.8 83.0 ± 0.1
Petromica citrina E9 16.6 ± 0.3 – >1000
Polymastia robusta E8 17.1 ± 0.7 – >1000
Tethya maza E10 14.1 ± 0.2 – >1000
Tunicates
Didembun perlucidum AS1 17.2 ± 0.6 – >1000
Polyclinum sp. AS2 18.2 ± 0.5 – >1000
Bryozoa
Bugula neritina B1 21.8 ± 0.2 7.8 ± 0.6 >1000
Sea  anemone
Bunodosoma caissarum AN1 24.5 ± 0.9 – >1000
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aa mg  GA/g = mg  of gallic acid equivalents/g dried extract.
b mg  AA/g = mg  of ascorbic acid equivalents/g dried extract.
cavenging DPPH and reducing potential (or iron-reducing) meth-
ds.
The objective of DPPH test was to measure the capacity
f the extracts to scavenge the stable radical 2,2-diphenyl-1-
icrylhydrazyl (DPPH) formed in solution by donation of hydrogen
tom or an electron. It has been documented that antioxidant
ompounds as cysteine, glutathione, ascorbic acid, tocopherol, and
olyhydroxy aromatic compounds (e.g., hydroquinone, pyrogallol,
allic acid) reduce and decolorize 1,1-diphenyl-2-picrylhydrazil
y their hydrogen donating capabilities (Blois, 1958). Antioxidant
romising results in DPPH test are expressed by samples with low
C50 (g/ml) values.
The reducing potential assay measures the total antioxidant
apacity of an extract evaluating the redox potentials of its com-
ounds. By this method the best results are expressed by samples
ith high mg  AA/g (g/ml) values.
The antioxidant properties were also evaluated, as well as the
henolic content of extracts was described and the obtained results
ere listed in Table 5.
Seaweeds and invertebrates’s extracts in general showed weak
ntioxidant activities, and only one out of 29 species assayed [E7
Ircinia sp.)] showed some antioxidant activity by DPPH assay
83.0 g/ml). The E7 also exhibited a good antioxidant result by
educing potential method (52.0 ± 0.8 mg  AA/g) (Table 5).
Phenolic compounds have been shown to possess important
ntioxidant activities based on their structural characteristics
Dimitrios, 2006). Thus, the total phenolics content from these
amples by the Folin–Ciocalteu reagent was also determined. The
nalysis detected a low phenolic content for all samples assayed,except for E7 that exhibited higher phenols content (61.9 mg  GA/g)
when compared to other marine extracts tested. These results are
compatible to the antioxidant activities observed (Table 5).
In a previous study, Zubia et al. (2007) showed that extracts from
48 Mexican marine seaweed species exhibited good antioxidant
activity in DPPH assay. Our results are not in agreement with ﬁnd-
ings for C. cervicornis (= D. cervicornis), L. variegata, P. gymnospora,
Digenia simplex, and L. dendroidea (= L. obtusa),  and this discrep-
ancy may  be due to the different geographic regions where this
species was  collected, such as seawater conditions, depth, salinity
and temperature (Table 5).
Anticholinesterase assay
The acetylcholinesterase (AChE) inhibition was determined
using an adaptation of the method published by Ingkaninan et al.
(2003). Extracts from seaweeds and invertebrates were tested and
results are depicted in Table 6.
Twenty-nine out of 29 marine species assayed (100%) showed
some anti-AChE activity, with IC50 < 1000 g/ml. In general, it was
observed that extracts from seaweeds have shown to be more
promising than extracts from marine invertebrates, exhibiting
the lowest IC50 values. Out of these fourteen seaweed species
tested, A10 (IC50 14.4 ± 0.1 g/ml), A16 (IC50 16.4 ± 0.4 g/ml)
and A8 (IC50 14.9 ± 0.5 g/ml) showed the best results, followed
by A13 (IC50 29.0 ± 0.6 g/ml), A3 (IC50 31.3 ± 0.4 g/ml), A9
(IC50 33.7 ± 0.2 g/ml), A4 (IC50 36.4 ± 0.5 g/ml) and A11 (IC50
36.9 ± 0.5 g/ml) (Table 6). In this study, seaweed species from
the phylum Rhodophyta exhibited better results than species
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Table  6
Anticholinesterase activity of marine seaweeds and invertebrates extracts.
Species Extracts IC50 (g/ml)
Seaweeds
Anadyomene saldanhae A17 161.9 ± 0.4
Canistrocarpus cervicornis A1 64.9 ± 0.9
Chaetomorpha antennina A13 29.0 ± 0.6
Dictyota mertensii A15 61.2 ± 0.1
Digenia simplex A9 33.7 ± 0.3
Gracilaria sp. A11 36.9 ± 0.5
Hypnea musciformis A10 14.4 ± 0.1
Laurencia dendroidea A7 99.8 ± 0.3
Laurencia translucida A16 16.4 ± 0.4
Lobophora variegata A4 36.4 ± 0.5
Padina gymnospora A3 31.3 ± 0.4
Palisada perforata A8 14.9 ± 0.5
Sagassum vulgare var. nanun A5 66.4 ± 0.4
Sargassum vulgare var. vulgare A6 71.2 ± 0.1
Sponges
Amphimedon viridis E2 118.0 ± 0.5
Aplysina fulva E1 65.9 ± 0.4
Desmacidon fruticosum E4 645.1 ± 0.8
Desmapsamma anchorata E3 385.5 ± 0.2
Dysidea cf.  fragilis E5 141.2 ± 0.6
Haliclona oculata E6 728.9 ± 0.8
Hymeniacidon heliophila E11 981.7 ± 0.1
Ircinia sp. E7 544.7 ± 0.2
Petromica citrina E9 450.4 ± 0.6
Polymastia robusta E8 508.5 ± 0.5
Tethya maza E10 >1000
Tunicates
Didembun perlucidum AS1 635.1 ± 0.6
Polyclinum sp. AS2 772.6 ± 0.6
Bryozoans
Bugula neritina B1 995.6 ± 0.8
Sea anemone
Bunodosoma caissarum AN1 539.5 ± 0.0
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ositive control = galantamine.
rom Chlorophyta and Ochrophyta. From these, A10 (H. musci-
ormis),  A16 (Laurencia translucida) and A8 (Palisada perforata) were
he most promising and are known for exhibiting bromine and
hlorine-containing C15 terpenoid and nonterpenoid (acetogenins)
etabolites (Ericson, 1983; Pereira and Teixeira, 1999).
Inhibition of acetylcholinesterase has been considered as a
romising approach for the treatment of Alzheimer’s disease and
or possible therapeutic applications in the treatment of Parkinson’s
isease, aging, and myasthenia gravis (Quinn, 1987). Thus, ﬁnding
ew cholinesterase inhibitors is considered very important. The
xtracts evaluated in this work showed that in addition to inhibiting
he cholinesterase enzyme, they also had antimicrobial (including
ntimollicutes) and antioxidant activities.
Further research aiming at isolating speciﬁc compounds respon-
ible for these activities, chemical analysis and new biological
tudies is required.
onclusions
In this work, 31 different extracts from 29 Brazilian marine
rganisms (seaweeds and invertebrates) were tested as antimicro-
ial, antioxidant and anti-acetylcholinesterase agents. The studies
howed that 71% of seaweeds assayed showed some activity against
. aureus and E. coli.  From these, the most promising antimicrobial
esults were found for A5 (S. vulgare var. nanun)  and A7 (L. den-
roidea) with MIC  250 g/ml. Almost all seaweeds assayed (92%)
xhibited some antimicrobial activity against mollicutes strains (M.
ominis, M.  genitalium,  M.  capricolum and M. pneumoniae strain
H). From these, A1 (C. cervicornis), A4 (L. variegata) and A11armacognosia 25 (2015) 668–676 675
(Gracilaria sp.) showed the best results for M.  pneumoniae strain
FH (MIC 250 g/ml). Concerning antibacterial activity from marine
invertebrates, only the extract B1 from the bryozoan B. neritina was
active against S. aureus (MIC 62.5 g/ml).
In general, all extracts tested showed weak antioxidant activ-
ities. Only E7 (from Ircinia sp.) showed some antioxidant activity
by DPPH assay (83.0 g/ml). However, 100% of extracts evaluated
showed some anti-AChE activity (IC50 < 1000 g/ml). From these,
A10 (H. musciformis), A16 (L. translucida) and A8 (P. perforata) exhib-
ited the most promising results (IC50 14.4, 16.4 and 14.9 g/ml),
respectively.
This study also showed for the ﬁrst time a screening for anti-
mollicutes agents from Brazilian and Spanish marine organisms
and the importance of bioprospecting studies of marine biodiver-
sity for bioactive natural compounds discovery and development of
new drugs. All the active extracts deserve special attention in fur-
ther studies, such as isolation and structure determination, as well
as more reﬁned biological assays; since clearly, Brazilian species
assayed could play an important source for the development of
new biotechnological products.
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